Testing the Performance of Smartphones and Their Accessories in Detecting Irregularly Irregular Heart Rhythm
Smartphone-Based Use of Phonocardiography, Electrocardiography Accessory, and/or Facial Photoplethysmography to Detect Atrial Fibrillation: Diagnostic Performance Study
2 other identifiers
observational
209
1 country
1
Brief Summary
The purpose of this 4-in-1 observational study is to test the performance of artificial intelligences (AIs) in distinguishing irregularly irregular heart rhythm called atrial fibrillation (AF) from normal heart rhythm using physiological signals collected by smartphones' built-in hardware and/or external accessories. Participants will:
- Have their weight, height, resting heart rate and blood pressures measured
- Have 12-lead electrocardiogram (ECG) of their heart electrical activities recorded
- Have their heart sounds and 1-lead ECG recorded from their chest, and optical-based blood flow data (photoplethysmography or PPG) and 1-lead ECG recorded from their fingers using smartphones' built-in microphone, camera, and/or external accessories
- Optionally have their optical-based blood flow data recorded from their face using smartphones' built-in camera (remote PPG or rPPG). The researchers will also create a database containing the physiological signals collected in this study along with the participants' medically relevant information to help train and test future AIs for medical applications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2025
CompletedStudy Start
First participant enrolled
August 27, 2025
CompletedFirst Posted
Study publicly available on registry
September 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
December 31, 2025
December 1, 2025
11 months
August 26, 2025
December 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differentiation of Atrial Fibrillation from Sinus Rhythm in Heart Sound Recordings
AUSC-AF: Identification of atrial fibrillation (AF) from sinus rhythm in recorded heart sounds (phonocardiogram \[PCG\]) as verified by the gold standard 12-lead electrocardiography (ECG) interpretation, measured in the form of sensitivity and specificity.
Day 0
Secondary Outcomes (4)
Differentiation of Atrial Fibrillation from Sinus Rhythm in Heart Sound Recordings
Day 0
Differentiation of Atrial Fibrillation from Sinus Rhythm in 1-Lead ECG Signals
Day 0
Differentiation of Atrial Fibrillation from Sinus Rhythm in PCG and 1-Lead ECG Signals
Day 0
Differentiation of Atrial Fibrillation from Sinus Rhythm in Facial Photoplethysmography Signals
Day 0
Study Arms (2)
Atrial Fibrillation
Sinus Rhythm
Interventions
Computer algorithms that are designed to perform heart sound, electrocardiography (ECG), and/or facial photoplethysmography (rPPG) analysis on data collected from smartphone's internal hardware and/or external accessories.
Eligibility Criteria
Hospital cardiology patients
You may qualify if:
- Age: ≥22 years (adult)
- Patients who have one of the following:
- Permanent atrial fibrillation, or
- Long-standing persistent atrial fibrillation (12 months or longer), or
- Confirmed 12-lead ECG diagnosis for persistent atrial fibrillation (\> 7 days) or sinus rhythm within 12 months at the time of their normal attendance at the hospital
You may not qualify if:
- Any of the following:
- Implanted active medical devices in the torso, such as pacemakers and defibrillators
- Patients without atrial fibrillation who have another arrhythmia
- Completely missing one or more limbs, or missing any hand
- Disability in using their hands or arms
- Lack of both index fingers, or all fingers in any hand
- Both index fingers with any of the following characteristics:
- Tattooed/inked
- Reduced blood flow in the fingertip (e.g. perniosis or callus formation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Mary Hospital
Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
August 26, 2025
First Posted
September 4, 2025
Study Start
August 27, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
December 31, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share